NCT05221151

Brief Summary

preoperative melatonin, pregabalin or both will be given to all patients preoperative

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
78

participants targeted

Target at P25-P50 for phase_4 anxiety

Timeline
Completed

Started Jan 2022

Shorter than P25 for phase_4 anxiety

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 7, 2022

Completed
23 days until next milestone

Study Start

First participant enrolled

January 30, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

February 2, 2022

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 2, 2022

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 2, 2022

Completed
Last Updated

December 21, 2022

Status Verified

December 1, 2022

Enrollment Period

3 months

First QC Date

January 7, 2022

Last Update Submit

December 19, 2022

Conditions

Keywords

melatoninpregabalin

Outcome Measures

Primary Outcomes (2)

  • VAS

    change of VAS of the patient on a scale from the night before surgery

    on arrival to operating room then every 6 hours untill 48 hours

  • Ramsey Sedation scale

    change of sedation of the patient on a scale from the night before surgery

    on arrival to operating room then every 6 hours untill 48 hours

Study Arms (3)

melatonin

ACTIVE COMPARATOR

26 patients will receive melatonin 10 mg

Drug: MelatoninDrug: Ondansetron 4 MG

pregabalin

ACTIVE COMPARATOR

26 patients will receive pregabalin 150 mg

Drug: PregabalinDrug: Ondansetron 4 MG

melatonin and pregabalin

ACTIVE COMPARATOR

26 patients will receive melatonin 5 mg plus pregabalin 75 mg

Drug: MelatoninDrug: PregabalinDrug: Ondansetron 4 MG

Interventions

In the night before surgery, 90 minutes before administering the intrathecal anesthesia and 12 hr after surgery

melatoninmelatonin and pregabalin

In the night before surgery, 90 minutes before administering the intrathecal anesthesia and 12 hr after surgery

melatonin and pregabalinpregabalin

before spinal anaesthesia

melatoninmelatonin and pregabalinpregabalin

Eligibility Criteria

Age55 Years - 85 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ASA I or II
  • patients undergoing hip arthroplasty
  • patient consent for spinal anaesthesia
  • patient alert, concious and good mental condition

You may not qualify if:

  • Patients with any neurolgical or psychiatric history before the procedure
  • Patients with a history of chronic pain
  • patients with known allergy to any of this study drugs
  • patients have Any contraindication to neuraxial block.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Medicine, University Hospitals

Shibīn al Kawm, Menoufia, 32511, Egypt

Location

MeSH Terms

Conditions

Anxiety Disorders

Interventions

MelatoninPregabalinOndansetron

Condition Hierarchy (Ancestors)

Mental Disorders

Intervention Hierarchy (Ancestors)

TryptaminesIndolesHeterocyclic Compounds, 2-RingHeterocyclic Compounds, Fused-RingHeterocyclic CompoundsHormonesHormones, Hormone Substitutes, and Hormone Antagonistsgamma-Aminobutyric AcidAminobutyratesButyratesAcids, AcyclicCarboxylic AcidsOrganic ChemicalsAmino AcidsAmino Acids, Peptides, and ProteinsImidazolesAzolesHeterocyclic Compounds, 1-RingCarbazolesHeterocyclic Compounds, 3-Ring

Study Design

Study Type
interventional
Phase
phase 4
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
lecturer

Study Record Dates

First Submitted

January 7, 2022

First Posted

February 2, 2022

Study Start

January 30, 2022

Primary Completion

May 2, 2022

Study Completion

October 2, 2022

Last Updated

December 21, 2022

Record last verified: 2022-12

Data Sharing

IPD Sharing
Will not share

Locations